Effects on sleep and wakefulness of the injection of hypocretin-1 (orexin-A) into the laterodorsal tegmental nucleus of the cat

被引:137
|
作者
Xi, MC
Morales, FR
Chase, MH [1 ]
机构
[1] Univ Calif Los Angeles, Sch Med, Dept Physiol, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, Sch Med, Brain Res Inst, Los Angeles, CA 90095 USA
关键词
microinjection; arousal; active sleep; lateraldorsal tegmental nucleus; cat;
D O I
10.1016/S0006-8993(01)02317-4
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Anatomical data demonstrate a dense projection, in the cat, from hypocretin (orexin) neurons in the hypothalamus to the laterodorsal tegmental nucleus (LDT), which is a critical pontine site that is involved in the regulation of the behavioral states of sleep and wakefulness. The present study was therefore undertaken to explore the hypocrerinergic control of neurons in the LDT vis-a-vis these behavioral states. Accordingly, hypocretin-1 was microinjected into the LDT of chronic, unanesthetized cats and its effects on the percentage, latency, frequency and duration of wakefulness, quiet (non-REM) sleep and active (REM) sleep were determined. There was a significant increase in the time spent in wakefulness following the microinjection of hypocretin-1 into the LDT and a significant decrease in the time spent in active sleep. The increase in the percentage of wakefulness was due to an increase in the duration of episodes of wakefulness; the reduction in active sleep was due to a decrease in the frequency of active sleep episodes, but not in their duration. These data indicate that hypocretinergic processes in the LDT play an important role in both of the promotion of wakefulness and the suppression of active sleep. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:259 / 264
页数:6
相关论文
共 50 条
  • [1] The effect of intranasal orexin-A (hypocretin-1) on sleep, wakefulness and attention in narcolepsy with cataplexy
    Weinhold, Sara Lena
    Seeck-Hirschner, Mareen
    Nowak, Alexander
    Hallschmid, Manfred
    Goeder, Robert
    Baier, Paul Christian
    BEHAVIOURAL BRAIN RESEARCH, 2014, 262 : 8 - 13
  • [2] Excitatory effects of hypocretin-1 (orexin-A) in the trigeminal motor nucleus are reversed by NMDA antagonism
    Peever, JH
    Lai, YY
    Siegel, JM
    JOURNAL OF NEUROPHYSIOLOGY, 2003, 89 (05) : 2591 - 2600
  • [3] LASTING EFFECTS OF EARLY POSTNATAL USE OF CLOMIPRAMINE ON SLEEP-WAKEFULNESS CYCLE ARE AMELIORATED BY ICV MICROINJECTION OF OREXIN-A (HYPOCRETIN-1) AND OREXIN-B (HYPOCRETIN-2)
    Maglakelidze, N.
    Mchedlidze, O.
    Dzadzamia, S.
    Tsomaia, V.
    Shavgulidze, M.
    Rogava, N.
    Bejanishvili, K.
    Nachkebia, N.
    SLEEP MEDICINE, 2017, 40 : E206 - E206
  • [4] CSF hypocretin-1 (OREXIN-A) measurement in pediatric and teenage patients with sleep disorders
    Arii, J.
    Kanbayashi, T.
    Hishikawa, Y.
    Shimizu, T.
    Maruyama, F.
    Narumi, A.
    Yano, T.
    Suda, H.
    Kaneko, Y.
    SLEEP, 2008, 31 : A218 - A218
  • [5] Orexin-A (hypocretin-1) levels in cerebrospinal fluid of patients with sleep and neurologic disorders
    Baumann, CR
    Maly, F
    Bischof, M
    Bassetti, CL
    SLEEP, 2003, 26 : A352 - A352
  • [6] Hypocretin1/orexin-A release across the sleep-wakefulness cycle
    Kiyashchenko, LI
    Mileykovskiy, BY
    Maidment, N
    Siegel, JMI
    SLEEP, 2002, 25 : A288 - A288
  • [7] Retrograde study of hypocretin-1 (orexin-A) projections to subdivisions of the dorsal raphe nucleus in the rat
    Lee, HS
    Park, SH
    Song, WC
    Waterhouse, BD
    BRAIN RESEARCH, 2005, 1059 (01) : 35 - 45
  • [8] Direct and indirect excitation of laterodorsal tegmental neurons by hypocretin/orexin peptides: Implications for wakefulness and narcolepsy
    Burlet, S
    Tyler, CJ
    Leonard, CS
    JOURNAL OF NEUROSCIENCE, 2002, 22 (07): : 2862 - 2872
  • [9] Effects of intranasal hypocretin-1 (orexin A) on sleep in narcolepsy with cataplexy
    Baier, P. C.
    Hallschmid, M.
    Seeck-Hirschner, M.
    Weinhold, S. L.
    Burkert, S.
    Diessner, N.
    Goeder, R.
    Aldenhoff, J. B.
    Hinze-Selch, D.
    SLEEP MEDICINE, 2011, 12 (10) : 941 - 946
  • [10] Increased CSF hypocretin-1 (orexin-A) in restless legs syndrome
    Allen, RP
    Mignot, E
    Ripley, B
    Nishino, S
    Earley, CJ
    NEUROLOGY, 2002, 59 (04) : 639 - 641